Advertisement

No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer

0

Authors say large, multisite study should provide reassurance for short-term risk

Personalized Cognitive Training Via Serious Video Game Aids ADHD Symptoms

0

Benefits seen for material organization, working memory, and inhibition

Trump Issues Executive Order Withdrawing U.S. From WHO

0

WHO issues statement citing work the United States and WHO have done together and expressing hope for maintaining partnership

Bird Flu Found in Georgia Commercial Poultry for First Time

0
By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- For the first time, bird flu has been detected in a commercial poultry...

Clinical Practice Guidelines Updated for Management of Stroke Rehab

0

47 recommendations developed in areas relevant to primary care, including transition to community, motor therapy, mental health

GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss

0

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders

Websites Selling Compounded GLP-1 RAs Often Misinform Consumers

0

Only 34 of 79 websites stated that compounded drugs were not FDA approved; 39 websites did not report adverse effects, warnings

1999 to 2021 Saw Rise in Methamphetamine-Related Mortality

0

This trend may be driven by increases in heroin and synthetic opioids coinvolvement

Moderna Receives $590M From HHS to Develop Bird Flu Vaccine

0
By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical...

2011 to 2022 Saw Increasing Prevalence of Poor Mental Health

0

Inequities noted in outcomes by age, sex, and racial and ethnic group